Filing Details
- Accession Number:
- 0001437749-24-007662
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-13 16:52:24
- Reporting Period:
- 2024-03-12
- Accepted Time:
- 2024-03-13 16:52:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1407451 | N Laurence Charney | 3020 Carrington Mill Blvd, Suite 475 Morrisville NC 27560 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-12 | 22,000 | $15.97 | 215,229 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- These shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations.
- Reflects the weighted average sale price. The range of prices for the shares sold was $15.95 to $16.00. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- Includes shares of restricted Common Stock, which vest over various time periods.